CROI 2016 Program at a Glance

Program and Agenda

627 Multiple HPV Genotypes As a Risk Factor for High Grade AIN in HIV-1 Infected Males Cristina Rovelli 1 ; Andrea Poli 2 ; Massimo Cernuschi 3 ; Andrea Marco Tamburini 3 ; Sara Racca 3 ; Laura Galli 3 ; GiuseppeTambussi 3 ; Antonella Castagna 3 ; Adriano Lazzarin 4 ; Silvia Nozza 3 1 UniversitàVita-SaluteSanRaffaele,Milano, Italy; 2 UniversitàVita- SaluteSanRaffaele,Milan, Italy; 3 SanRaffaeleScientific Inst,Milan, Italy; 4 Vita-SaluteUniv,SanRaffaeleScientific Inst,Milan, Italy 628 Prevalence of HPV-Related Lesions in an Urban Cohort of HIV-Positive Men in Germany Wolfgang Fuchs 1 ; UlrikeWieland 2 ; Adriane Skaletz-Rorowski 3 ; Jochen Swoboda 4 ; Alexander Kreuter 5 ; Claudia Michalik 6 ; Anja Potthoff 7 ; Norbert H. Brockmeyer 1 ; for the Competence Network for HIV/AIDS 1 Clinic forDermatology,Ruhr-UniversitätBochum,Germany,Bochum, Germany; 2 NatlReferenceCntr forPapilloma-andPolyomaviruses,Univ ofCologne,Cologne,Germany; 3 CompetenceNetwork forHIV/AIDS,Ruhr- Universität,Bochum,Germany; 4 InstofCytology,Bonn,Germany; 5 Helios St.ElisabethHospOberhausen,Oberhausen,Germany; 6 KompNetHIV/ AIDS,Bochum,Germany; 7 FachklinikumBorkum,Borkum,Germany 2:45 PM-4:00 PM Atherosclerosis Pathogenesis: Role of the Immune System 651 Correlates and Longitudinal Implications of FGF23 Levels in HIV-Positive Individuals Mohamed G. Atta 1 ; Michelle Estrella 2 ; Derek M. Fine 1 ; Katie Zook 1 ; Jose Manuel MonroyTrujillo 2 ; James H. Stein 3 ; Gregory M. Lucas 1 1 JohnsHopkinsUniv,Baltimore,MD,USA; 2 JohnsHopkinsUnivSchof Med,Baltimore,MD,USA; 3 UnivofWisconsin-Madison,Madison,WI, USA 652 Nonclassical Monocyte, MCP-1 Predict Subclinical Atherosclerosis Progression in HIV 1 UnivofHawaii,Honolulu,HI,USA; 2 UnivofSouthernCalifornia,Los Angeles,CA,USA; 3 Harbor-UnivofCaliforniaLosAngelesMedCntr, Torrance,CA,USA; 4 BloodSystemsRsr Inst,SanFrancisco,CA,USA 653 Association of T Cell and Macrophage ActivationWith Vascular Health in HIV Heather Grome ; Louise Barnett; Cindy Hager;Timothy R. Sterling; Spyros A. Kalams; John R. Koethe VanderbiltUnivSchofMed,Nashville,TN,USA 654 Effect of T-Cell Activation and Inflammation on Endothelial Dysfunction in HIV Arjun Sinha ;Yifei Ma; Rebecca Scherzer; Danny Li; Steven G. Deeks; Peter Ganz; Priscilla Hsue UnivofCaliforniaSanFrancisco,SanFrancisco,CA,USA Session P-P3 Poster Abstracts Hall A/B Dominic C. Chow 1 ; Lishomwa C. Ndhlovu 1 ; Lindsay M. Kohorn 1 ; Guangxiang Zhang 1 ; Howard N. Hodis 2 ; Matthew Budoff 3 ;Yanjie Li 2 ; Sheila M. Keating 4 ; Philip J. Norris 4 ; Cecilia M. Shikuma 1

655 CCR5+CD8+ T-Cell Levels Are AssociatedWith Cardiovascular Events in Patients on cART LauraTarancón 1 ; Rebeca S. de Pablo 2 ; Isaac Rosado 3 ; Beatriz Dominguez 3 ; Miguel Genebat 4 ; María José Polaino 5 ; Mohammed Rafii-El-Idrissi Benhnia 4 ;Yolanda M. Pacheco 3 ; Manuel Leal 4 ; Ezequiel Ruiz-Mateos 4 1 BioMed InstofSevilla,Sevilla,Spain; 2 BioMed InstofSeville,Sevilla, Spain; 3 InstofBioMedofSeville (IBiS),Seville,Spain; 4 BioMed Instof Seville,Seville,Spain; 5 BioMed InstofSeville,Sevilla,Spain 656 Soluble TWEAK May Predict Carotid Atherosclerosis in Treated HIV Infection Sahera Dirajlal-Fargo 1 ; Abdus Sattar 2 ; Manjusha Kulkarni 3 ; Nicholas T. Funderburg 3 ; Grace A. McComsey 1 1 CaseWesternReserveUniv,Cleveland,OH,USA; 2 CaseWesternReserve UnivSchofMed,Cleveland,OH,USA; 3 OhioStateUniv,Columbus,OH, USA 657 Diet, Gut Integrity Markers, and Cardiovascular Disease Risk in HIV+ Adults Allison R.Webel 1 ; Abdus Sattar 2 ; NicholasT. Funderburg 3 ; Bruce Kinley 1 ; ChrisT. Longenecker 1 ; Danielle Labbato 1 ; Morgan Boucher 3 ; Grace A. McComsey 1 1 CaseWesternReserveUniv,Cleveland,OH,USA; 2 CaseWesternReserve UnivSchofMed,Cleveland,OH,USA; 3 OhioStateUniv,Columbus,OH, USA 2:45 PM-4:00 PM Cardiovascular Disease and Antiretroviral Therapy Effects 658 Does Pulse-Wave Velocity NormalizeWith Increasing Time on ART? Evidence From CHER Steve Innes 1 ; Mark F. Cotton 1 ; Kennedy Otwombe 2 ; Philip G. Herbst 3 ; Barbara Laughton 1 ; Richard Haubrich 4 ; Sara H. Browne 4 1 StellenboschUnivandTygerbergChildren’sHosp,CapeTown,South Africa; 2 Univof theWitwatersrand, Johannesburg,SouthAfrica; 3 StellenboschUnivandTygerbergAcademicHosp,CapeTown,South Africa; 4 UnivofCaliforniaSanDiego,SanDiego,CA,USA 659 Changes in CVD Risk Factors With Early and Deferred ART in the START Trial JasonV. Baker 1 ; Shweta Sharma 2 ; for theThe INSIGHT START (StrategicTiming of AntiRetroviralTreatment) Study Group 1 HennepinCountyMedCntr,UnivofMinnesota,Minneapolis,MN,USA; 2 UnivofMinnesota,Minneapolis,MN,USA 660 Cardiovascular Biomarkers After Switch to ABC/ DTG/3TC: The STRIIVING Study Jordan Lake 1 ; Judith S. Currier 1 ; Justin Koteff 2 ; Clare Brennan 2 ; Catherine Granier 3 ; Mark Shaefer 2 ; Martin Gartland 2 ; BrianWynne 4 ; Michael Aboud 5 Session P-P4 Poster Abstracts

Hall A/B

Poster Listings

1 DavidGeffenSchofMedatUnivofCaliforniaLosAngeles,LosAngeles, CA,USA; 2 ViiVHlthcare,ResearchTrianglePark,NC,USA; 3 GSK,Middlesex, UK; 4 ViiVHlthcare,Collegeville,PA,USA; 5 ViiVHlthcare,Brentford,UK

92

CROI 2016